IBDEI1LB ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28223,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28223,1,4,0)
 ;;=4^690.18
 ;;^UTILITY(U,$J,358.3,28223,1,5,0)
 ;;=5^Dandruff
 ;;^UTILITY(U,$J,358.3,28223,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,28224,0)
 ;;=111.9^^162^1793^20
 ;;^UTILITY(U,$J,358.3,28224,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28224,1,4,0)
 ;;=4^111.9
 ;;^UTILITY(U,$J,358.3,28224,1,5,0)
 ;;=5^Dermatomycosis NOS
 ;;^UTILITY(U,$J,358.3,28224,2)
 ;;=^33149
 ;;^UTILITY(U,$J,358.3,28225,0)
 ;;=701.1^^162^1793^25
 ;;^UTILITY(U,$J,358.3,28225,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28225,1,4,0)
 ;;=4^701.1
 ;;^UTILITY(U,$J,358.3,28225,1,5,0)
 ;;=5^Dry Skin
 ;;^UTILITY(U,$J,358.3,28225,2)
 ;;=^66809
 ;;^UTILITY(U,$J,358.3,28226,0)
 ;;=705.81^^162^1793^26
 ;;^UTILITY(U,$J,358.3,28226,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28226,1,4,0)
 ;;=4^705.81
 ;;^UTILITY(U,$J,358.3,28226,1,5,0)
 ;;=5^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,28226,2)
 ;;=^96545
 ;;^UTILITY(U,$J,358.3,28227,0)
 ;;=782.7^^162^1793^27
 ;;^UTILITY(U,$J,358.3,28227,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28227,1,4,0)
 ;;=4^782.7
 ;;^UTILITY(U,$J,358.3,28227,1,5,0)
 ;;=5^Ecchymoses, Spontaneous
 ;;^UTILITY(U,$J,358.3,28227,2)
 ;;=^273359
 ;;^UTILITY(U,$J,358.3,28228,0)
 ;;=695.9^^162^1793^33
 ;;^UTILITY(U,$J,358.3,28228,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28228,1,4,0)
 ;;=4^695.9
 ;;^UTILITY(U,$J,358.3,28228,1,5,0)
 ;;=5^Erythematous Condition
 ;;^UTILITY(U,$J,358.3,28228,2)
 ;;=^123902
 ;;^UTILITY(U,$J,358.3,28229,0)
 ;;=785.4^^162^1793^34
 ;;^UTILITY(U,$J,358.3,28229,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28229,1,4,0)
 ;;=4^785.4
 ;;^UTILITY(U,$J,358.3,28229,1,5,0)
 ;;=5^Gangrene
 ;;^UTILITY(U,$J,358.3,28229,2)
 ;;=^49194
 ;;^UTILITY(U,$J,358.3,28230,0)
 ;;=704.9^^162^1793^35
 ;;^UTILITY(U,$J,358.3,28230,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28230,1,4,0)
 ;;=4^704.9
 ;;^UTILITY(U,$J,358.3,28230,1,5,0)
 ;;=5^Hair Disease NOS
 ;;^UTILITY(U,$J,358.3,28230,2)
 ;;=^53658
 ;;^UTILITY(U,$J,358.3,28231,0)
 ;;=705.83^^162^1793^36
 ;;^UTILITY(U,$J,358.3,28231,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28231,1,4,0)
 ;;=4^705.83
 ;;^UTILITY(U,$J,358.3,28231,1,5,0)
 ;;=5^Hidradenitis
 ;;^UTILITY(U,$J,358.3,28231,2)
 ;;=^184621
 ;;^UTILITY(U,$J,358.3,28232,0)
 ;;=703.8^^162^1793^40
 ;;^UTILITY(U,$J,358.3,28232,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28232,1,4,0)
 ;;=4^703.8
 ;;^UTILITY(U,$J,358.3,28232,1,5,0)
 ;;=5^Onychodystrphy/Gryphosis/Lysis
 ;;^UTILITY(U,$J,358.3,28232,2)
 ;;=^271926
 ;;^UTILITY(U,$J,358.3,28233,0)
 ;;=695.89^^162^1793^37
 ;;^UTILITY(U,$J,358.3,28233,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28233,1,4,0)
 ;;=4^695.89
 ;;^UTILITY(U,$J,358.3,28233,1,5,0)
 ;;=5^Intertrigo
 ;;^UTILITY(U,$J,358.3,28233,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,28234,0)
 ;;=214.9^^162^1793^38
 ;;^UTILITY(U,$J,358.3,28234,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28234,1,4,0)
 ;;=4^214.9
 ;;^UTILITY(U,$J,358.3,28234,1,5,0)
 ;;=5^Lipoma NOS
 ;;^UTILITY(U,$J,358.3,28234,2)
 ;;=^71155
 ;;^UTILITY(U,$J,358.3,28235,0)
 ;;=703.0^^162^1793^39
 ;;^UTILITY(U,$J,358.3,28235,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28235,1,4,0)
 ;;=4^703.0
 ;;^UTILITY(U,$J,358.3,28235,1,5,0)
 ;;=5^Onychocryptosis
 ;;^UTILITY(U,$J,358.3,28235,2)
 ;;=^81221
 ;;^UTILITY(U,$J,358.3,28236,0)
 ;;=528.2^^162^1793^42
 ;;^UTILITY(U,$J,358.3,28236,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28236,1,4,0)
 ;;=4^528.2
 ;;^UTILITY(U,$J,358.3,28236,1,5,0)
 ;;=5^Oral Aphthae
 ;;^UTILITY(U,$J,358.3,28236,2)
 ;;=^114480
 ;;^UTILITY(U,$J,358.3,28237,0)
 ;;=692.72^^162^1793^43
 ;;
 ;;$END ROU IBDEI1LB
